Price to Sales ratio Analysis of Kazia Therapeutics Ltd ADR - Deep Dive
WARN : Please note that some of the values may not be in base currency

Latest FY PS
Period Ending - Jun-23

110715


Very Poor PS
Period Ending - Jun-22
137766

Very Poor PS
Growth
-19.64 %
Trailing Twelve Months PS
Period Ending - Jun-23

74921.35


Very Poor PS
PS Analysis of Kazia Therapeutics Ltd ADR
P/S Ratio of Kazia Therapeutics Ltd ADR with value of 74921.35 indicates that stock price is high compared to sales of the company and may be overvalued.
PS Ratio of KZIA has fallen by -19.64 % Compared to previous Financial Year.
PS Ratio with value of 137766 was highest in Year Jun-22 in last Five Years.
PS Ratio with value of 0.202 was lowest in Year Jun-21 in last Five Years.
Latest PS Ratio with value of 110715 is Greater than Average PS of 50245.46 in last five years.
Other PS Related Info of KZIA that may interest you.
Kazia Therapeutics Ltd ADR Overview
CodePricePrevious PricePrice ChangeSector
KZIA0.260.2497 4.12 % Biotechnology
Fundamental AnalysisTechnical Analysis
Defination of Price to Sales
The Price to Sales Ratio indicates how much investors are willing to pay for each rupee of sales generated by a company. Price-to-Sales Ratio is used to determine whether a stock is currently profitable or less profitable, which is helpful for better investment decisions.   more ..
Price to Sales Formula

PS Related Ratios
PriceToBookRatioPriceToEarningRatioAssetTurnoverRatio

Tsr Value Index
Poor Value Stock
FY - Historical Price to Sales of Kazia Therapeutics Ltd ADR
PeriodJun-23Jun-22Jun-21Jun-20Jun-19Jun-18Jun-17
PS1107151377660.2021790.19955.3395.960.0346
Change-19.64 %68366666 %-99.99 %87.39 %895.59 %277211 %-94.95 %
You are view first 7 Records. Log in to view all 25 in Premium view
FY Chart of Price to Sales of Kazia Therapeutics Ltd ADR


Note : All Data Generated at the End of Trading Hours (EOD Data)